An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol

Hua Ling, Tammy L. Burns, Daniel E. Hilleman

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterol'. Together they form a unique fingerprint.

Medicine & Life Sciences